Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: ncRNAs-mediated overexpression of STIL predict unfavorable prognosis and correlated with the efficacy of immunotherapy of hepatocellular carcinoma

Fig. 2

The expression of STIL and its relationships with clinicopathologic factors. The median value of STIL expression was set as the cut-off value. The Wilcoxon signed-rank test was applied to examine the association between clinicopathological varieties and the expression of STIL in 374 HCC samples. A Age, B histological grade, C T stage, D TNM stage, and E AFP levels. STIL STIL centriolar assembly protein; HCC hepatocellular carcinoma

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us